Cite
HARVARD Citation
Gebbia, V. et al. (2020). Abemaciclib: safety and effectiveness of a unique cyclin-dependent kinase inhibitor. Expert opinion on drug safety. 19 (8), pp. 945-954. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Gebbia, V. et al. (2020). Abemaciclib: safety and effectiveness of a unique cyclin-dependent kinase inhibitor. Expert opinion on drug safety. 19 (8), pp. 945-954. [Online].